Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

ABPI code

Pharma company accused of ‘bribing’ prescribers slammed by PMCPA

December 17, 2015 Medical Communications ABPI Code, Daily Telegraph, PMCPA, Prescription Medicines Code of Practice Authority, Stirling Anglian

Stirling Anglian, the company at the centre of media criticism for arranging meetings at lavish hotels in an attempt to …
News
Shkreli KaloBios

Turing chief exec Martin Shkreli arrested

December 17, 2015 Medical Communications, Sales and Marketing Daraprim, FBI, Martin Shkreli, Shkreli, turing

Turing chief executive Martin Shkreli has been arrested on a charge of securities fraud relating to a company he founded, …
News
kelner_rob_070427

Valeant hires attorney and crisis management firm to handle bad US PR

December 17, 2015 Medical Communications, Sales and Marketing Robert Kelner, Valeant, Vianovo. Covington & Burling

Valeant has retained attorney Robert Kelner, a partner at the law firm Covington & Burling, to help the beleaguered pharma …
Appointment
jessica_fine

MSD UK appoints Jessica Fine as executive director of external affairs

December 16, 2015 Medical Communications Jessica Fine, MSD

MSD has appointed former Lexington Health boss Jessica Fine to lead its external affairs team in the UK from April …
Appointment
tony_gardiner

Avacta appoints Tony Gardiner as chief financial officer

December 16, 2015 Medical Communications Avacta Group

Avacta Group, the developer of Affimer biotherapeutics and research reagents, has appointed Tony Gardiner as group chief financial officer. Gardiner …
Appointment
juan_luciano

Juan Luciano appointed to Eli Lilly board

December 16, 2015 Medical Communications Eli Lilly

The board of directors of Eli Lilly has elected Juan Luciano as a new member, effective February 1 2016. Luciano …
Appointment

Precious Cells Group appoints David Huse in expansion push

December 15, 2015 Medical Communications, Research and Development Stem cells, precious cells group

Precious Cells Group, a UK-based international provider of stem cell storage and related technologies, has announced the appointment of commercial …
Appointment
personal-95715_640

Mirror. Signal. Merger. How to deal with a pharma takeover

December 14, 2015 Manufacturing and Production, Medical Communications, Sales and Marketing Deals, acquisition, buyouts, mergers, takeovers

So 2015 has been a record year for M&A in the pharma industry.The Financial Times has called this “the most …
Feature
Lynparza

NICE recommends AstraZeneca’s Lynparza after price reduction

December 11, 2015 Medical Communications, Sales and Marketing AstraZeneca, NICE, fallopian tube cancer, lynparza, olaparib, ovarian cancer, peritoneal cancer

NICE has recommended AstraZeneca’s Lynparza for maintenance treatment of relapsed ovarian, fallopian tube and peritoneal cancer. In draft guidance the …
News
roche_scientists

Which are pharma’s most innovative companies?

December 11, 2015 Medical Communications, Research and Development GSK, Roche, research and development

It has been a record-breaking year for the pharmaceutical industry in terms of deals, but what about the underlying innovation …
Feature
AZ_scientist

AstraZeneca deal to delve into the secretome

December 11, 2015 Medical Communications, Research and Development AstraZeneca, MedImmune, biologics, secretome

MedImmune, the biologics research and development arm of pharma giant AstraZeneca, has signed a collaboration with Swedish universities and research …
News

NICE publishes draft guidance on two prostate cancer treatments

December 11, 2015 Medical Communications, Research and Development, Sales and Marketing Astellas, Janssen, NICE, Xtandi, Zytiga, prostate cancer

NICE has issued final draft guidance recommending Astellas Pharma’s Xtandi (enzalutamide) in prostate cancer prior to chemotherapy, but not Janssen’s …
News
xarelto

Regulators to probe Bayer’s Xarelto trial results

December 10, 2015 Medical Communications, Research and Development

Bayer’s blockbuster anticoagulant Xarelto is under scrutiny from regulators in Europe and the US, as they try to determine whether …
News
cindy_whitehead

‘Female Viagra’ CEO leaves company

December 10, 2015 Medical Communications, Sales and Marketing Addyi, Cindy Whitehead, Sprout Pharma

Cindy Whitehead has left Sprout Pharmaceuticals, just four months after guiding the female libido drug Addyi to FDA approval and overseeing …
Appointment
mackayjimeson_1345198498_140

Two new corporate affairs leads appointed at Pfizer

December 9, 2015 Medical Communications Pfizer, corporate affairs

Pfizer has appointed MacKay Jimeson and Niesha Foster as corporate affairs leads. The company recently restructured its global pharma business …
Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026